TIMP1 linked to anoikis resistance and metastasis in esophageal cancer

Researchers have identified TIMP1 as a candidate regulator of anoikis resistance in esophageal squamous cell carcinoma, a cancer type in which tumor cells can survive after detaching from surrounding tissue and acquire traits associated with invasion and distant spread. Integrated single-cell and bulk RNA analyses produced a seven-gene prognostic model, while laboratory experiments showed that reducing TIMP1 levels suppressed several malignant behaviors in esophageal cancer cells and diminished tumor growth and lung colonization in nude mice.

Anoikis is a form of programmed cell death triggered when cells lose contact with the extracellular matrix. The researchers began by calculating anoikis-related signatures across cell types in single-cell RNA-sequencing data from esophageal squamous cell carcinoma, or ESCC. These scores revealed differences among cell populations, allowing the team to identify differentially expressed genes associated with the process. The investigators then used weighted gene co-expression network analysis on the GSE53625 bulk-transcriptomics cohort and intersected its results with the single-cell findings. This integration narrowed the search to 428 candidate anoikis-related genes.

The researchers next developed a risk model intended to estimate patient prognosis. Univariate Cox regression and least absolute shrinkage and selection operator, or LASSO, Cox regression were used to construct a seven-gene model comprising ATP8B3, KIF18B, TIMP1, BCAT1, SLC39A6, CLEC6A and TNS3. The model showed prognostic value in both the GSE53625 cohort and an independent cohort from The Cancer Genome Atlas. A nomogram was also created by integrating the gene-based risk score with clinicopathological features. The study therefore links molecular patterns of anoikis to outcome estimates in ESCC, but the risk model remains a research tool rather than a clinically validated test.

Among the model’s genes, TIMP1 was selected for functional testing. In vitro assays indicated that knocking down TIMP1 reduced ESCC cell proliferation, migration, invasion and colony formation. The same treatment reduced resistance to anoikis and increased apoptosis, supporting the hypothesis that TIMP1 helps tumor cells tolerate detachment from their substrate. In vivo experiments in nude mice provided a complementary result: TIMP1 knockdown suppressed growth of subcutaneous ESCC xenografts and reduced experimental pulmonary colonization. These findings are consistent with a role for TIMP1 in maintaining anoikis-resistant, metastatic phenotypes, although the experiments do not establish the full molecular route through which it acts.

The work points to TIMP1 as both a component of an ESCC prognostic signature and a biologically relevant candidate regulator, but several limitations remain. The downstream signaling mediators and direct molecular interactions connecting TIMP1 to anoikis resistance were not characterized. The clinical cohorts establish associations and prognostic performance rather than showing that the seven-gene model improves care, and the functional evidence comes from cultured cells and mouse xenograft models rather than human interventional studies. The researchers accordingly describe the results as a rationale for further mechanistic and translational investigation, not as an immediate basis for treatment selection or clinical decision-making.

Subject of Research: TIMP1 regulation of anoikis resistance and metastatic potential in esophageal squamous cell carcinoma

Article Title: Integrative single-cell and bulk transcriptomic analyses identify timp1 as a candidate regulator of anoikis resistance and metastatic potential in esophageal squamous cell carcinoma

Article References: Li, S., Liu, J., Wang, N., Tao, Z., Xie, K., Jiang, W., & Ma, H. (2026). Integrative single-cell and bulk transcriptomic analyses identify timp1 as a candidate regulator of anoikis resistance and metastatic potential in esophageal squamous cell carcinoma. BMC Cancer. https://doi.org/10.1186/s12885-026-17208-3

Image Credits: AI Generated

DOI: 10.1186/s12885-026-17208-3

Keywords: esophageal squamous cell carcinoma, TIMP1, anoikis resistance, single-cell RNA sequencing, transcriptomics, cancer metastasis, prognostic modeling, tumor invasion, xenograft models, Integrative, single-cell, bulk